India
Also, OMRON in Singapore has launched a new medical device plan featuring AI-driven recommendations for self-management of chronic diseases.
Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization.
The spin-off company is expected to rake in almost $2 billion in revenue this year.
40% of their time is spent on manually collecting data, which the tool would assist in reducing.
Indian e-clinic startup CureBay also looks to expand its rural network.
Maharashtra University of Health Sciences will explore the application of Nihilent's Navarasa AI in mental health care.
Also, Lytus adds an AI-driven blood logistics platform to its health technology portfolio.
Also, an AI-powered breath test for diagnosing silicosis has been developed in Sydney.
Also, Cureskin from India has launched an AI-powered hair analysis feature on its mobile application.
Also, South Korean medical AI companies JLK and Coreline Soft announced recent regulatory approvals in Japan and the United States.